A mountain of data says they are safe and effective.
Two doses of the mRNA COVID-19 vaccine among school-aged children safely and effectively reduces COVID-19 infection risk as well as associated risks for developing multisystem inflammatory syndrome and COVID-19 related hospitalizations, new data suggests.
This study adds evidence to existing studies and “supports the safety and efficacy of mRNA COVID-19 vaccine in children aged 5-11 years,” authors Dr. Jun Yasuhara of the Center for Cardiovascular Research at Nationwide Children’s Hospital and Dr. Toshiki Kuno of the Division of Cardiology at Montefiore Medical Center told ABC News.